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Polybrominated diphenyl ethers (PBDEs) 
have become ubiquitous environmental pol-
lutants because of their historical and wide-
spread use as flame retardants, and they have 
received great attention from ecological health 
and environmental perspectives (Athanasiadou 
et al. 2008; He et al. 2008; Lagalante et al. 
2009). Most recently, hydroxylated PBDEs 
(HO-PBDEs) have caused increasing concern 
because of reports of their natural production 
and metabolism (Hakk and Letcher 2003; 
Malmberg et al. 2005; Malmvarn et al. 2005; 
Mercado-Feliciano and Bigsby 2008; Wan 
et al. 2009). HO-PBDEs have been detected 
in the blood of fish, birds, and mammalian 
species and even in the abiotic environ  ment 
(Athanasiadou et al. 2008; Cantón et al. 2008; 
Lacorte and Ikonomou 2009). Recent studies 
(Dingemans et al. 2008; Qiu et al. 2009) sug-
gest that some of the toxic effects of PBDEs 
might be due to their HO metabolites.
In vitro tests have shown that certain 
PBDEs can affect thyroid hormone homeo-
stasis by acting as potent competitors of thyroid 
hormones for binding to human transthyretin 
(TTR) and thyroid hormone receptors (TRs) 
(Cantón et al. 2006; Darnerud et al. 2007; 
Zhou et al. 2002). For instance, levels of serum 
thyroxine (T4) were significantly decreased 
when rats were exposed to PBDEs (Zhou 
et al. 2002). The effects of PBDEs on T4   levels 
may require metabolic activation because 
HO-PBDEs, but not the PBDE congeners 
themselves, behave as ligands for human TTR 
in vitro (Meerts et al. 2000; Qiu et al. 2007). 
Kitamura et al. (2008) also reported that 
4-OH-BDE-90 and 3-OH-BDE-47 markedly 
inhibited the binding of triiodo  thyronine (T3) 
to TRα and acted as thyroid hormone-like 
agents. Recently, Kojima et al. (2009) reported 
that 4-HO-BDE-90 significantly inhibited 
TRα- and TRβ-mediated transcriptional activ-
ity induced by T3. Consequently, HO-PBDEs 
have attracted great attention (Routti et al. 
2009). However, there is lack of systematic 
investigation into the mechanisms by which 
HO-PBDEs interfere with hormonal actions 
(Zhao et al. 2008).
There are mainly two subtypes of TRs, 
TRα and TRβ, expressed from two differ-
ent genes. TRα mediates the effects of thy-
roid hormones on the heart, in particular on 
heart rate and rhythm, whereas most actions 
of the hormones on the liver and other tissues 
are mediated more through TRβ (Forrest and 
Vennstrom 2000). The initial step for chemical 
mode of action is binding to an intra  cellular 
receptor (Kavlock et al. 1996). Given the large 
number of compounds that may bind to the 
receptors, there is increasing interest in devel-
oping computational methods (in silico) to pre-
dict affinity of compounds with the receptors, 
including quantitative structure–activity rela-
tionships (QSARs) (Du et al. 2008; Valadares 
et al. 2007). Furthermore, molecular docking 
and virtual screening have become an integral 
part of many modern structure-based compu-
tational simulations of chemicals (Martinez 
et al. 2008). Docking methodologies use the 
knowledge of three-dimensional structure 
of a receptor in an attempt to optimize the 
bound ligand or a series of molecules into the 
active site. Combinational use of docking with 
QSAR can provide more information on the 
interaction between the ligand and the recep-
tor (Sippl 2002; Soderholm et al. 2005).
In this study, we applied an integrated 
in vitro and in silico approach to evaluate 
the thyroid hormone–disrupting potency of 
HO-PBDEs and to identify critical structural 
elements and physico  chemical properties of 
HO-PBDEs related to their hormone activ-
ity. The hormone activities of 18 HO-PBDEs 
to human TRβ were determined using 
the recombinant two-hybrid yeast assay. 
Molecular docking was performed to find 
the significant ligand–receptor interactions 
in the binding site of TRβ, which provided a 
better understanding of inter  actions between 
the HO-PBDEs and TRβ. Molecular struc-
tural descriptors were computed, selected, and 
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Ba c k g r o u n d: Hydroxylated polybrominated diphenyl ethers (HO-PBDEs) may disrupt thyroid 
hormone status because of their structural similarity to thyroid hormone. However, the molecular 
mechanisms of interactions with thyroid hormone receptors (TRs) are not fully understood.
oBjectives: We investigated the interactions between HO-PBDEs and TRβ to identify critical 
structural features and physico  chemical properties of HO-PBDEs related to their hormone activity, 
and to develop quantitative structure–activity relationship (QSAR) models for the thyroid hormone 
activity of HO-PBDEs.
Me t h o d s : We used the recombinant two-hybrid yeast assay to determine the hormone activities to 
TRβ and molecular docking to model the ligand–receptor interaction in the binding site. Based on 
the mechanism of action, molecular structural descriptors were computed, selected, and employed 
to characterize the interactions, and finally a QSAR model was constructed. The applicability 
domain (AD) of the model was assessed by Williams plot.
re s u l t s: The 18 HO-PBDEs tested exhibited significantly higher thyroid hormone activities than 
did PBDEs (p < 0.05). Hydrogen bonding was the characteristic interaction between HO-PBDE 
molecules and TRβ, and aromaticity had a negative effect on the thyroid hormone activity of 
HO-PBDEs. The developed QSAR model had good robustness, predictive ability, and mechanism 
interpretability.
co n c l u s i o n s: Hydrogen bonding and electrostatic interactions between HO-PBDEs and TRβ are 
important factors governing thyroid hormone activities. The HO-PBDEs with higher ability to accept 
electrons tend to have weak hydrogen bonding with TRβ and lower thyroid hormone activities.
key w o r d s : application domain, density functional theory, docking, HO-PBDEs, hydroxylated 
polybrominated diphenyl ethers, PBDEs, quantitative structure–activity relationship, thyroid hor-
mone receptor. Environ Health Perspect 118:602–606 (2010).  doi:10.1289/ehp.0901457 [Online 
17 December 2009]Thyroid hormone activity of HO-PBDEs and QSAR
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 5 | May 2010  603
employed to characterize the interactions, and 
finally we constructed QSAR models. We also 
assessed the applicability domain (AD) of the 
QSAR model. 
Materials and Methods
Chemicals. We selected 18 HO-PBDEs for 
the present study [see Supplemental Material, 
Figure S1 (doi:10.1289/ehp.0901457)]; 
most have been detected in environmental/ 
biological samples (Malmberg et al. 2005; 
Qiu et al. 2007). The HO-PBDEs conge-
ners (> 97% purity) were purchased from 
AccuStandard (New Haven, CT, USA). 
3,3´,5-Triiodothyronine (T3; 95% purity), 
dimethyl sulfoxide (DMSO; GC, 99.5% 
purity), o-nitrophenyl β-d-galactopyranoside 
(o-NPG; ≥ 98% purity), sodium dodecyl 
sulfate (99% purity), leucine (99% purity), 
trypto  phan (99% purity), yeast-based nitrogen 
(99% purity), and β-mercaptoethanol (99% 
purity) were purchased from Sigma Chemical 
Company (St. Louis, MO, USA). Stock solu-
tions of HO-PBDEs were prepared in DMSO.
Recombinant two-hybrid yeast assay and 
statistical analysis. The recombinant two-
hybrid yeast system employed a yeast cell 
transformed with the human TRβ plasmid, 
coactive plasmid, and the reporter gene express-
ing β-galactosidase (Li et al. 2008). We exam-
ined the specificity of the yeast two-hybrid 
assay for TRβ ligand using DMSO (control), 
T3, and other steroid hormones. T3 induced 
β-galactosidase activity, whereas 17β-estradiol, 
dihydro  testosterone, and progesterone did not. 
Thus, the recombinant two-hybrid yeast assay 
was highly specific for TRβ ligand without 
cross-talk to other receptor agonists.
We performed the recombinant two-
hybrid yeast assay as described previously by 
Li et al. (2008). Briefly, yeast transformants 
were grown overnight at 30°C, with vigor-
ous orbital shaking (130 rpm). For the assay, 
exponentially growing overnight cultures 
were diluted with synthetic dextrose/leucine/
tryptamine medium to an optical density at 
600 nm (OD600) of 0.75. All the samples were 
determined at least in triplicate. Each triplicate 
included a positive control (T3) and a negative 
control (DMSO). Each tested chemical was 
serially diluted in DMSO for a total of 7–11 
concentrations. Serial dilutions (5-µL steps) 
were combined with 995 µL medium contain-
ing 5 × 103 yeast cells/mL, resulting in a test 
culture in which the volume of DMSO did not 
exceed 0.5% of the total volume. For each test 
culture, 200 µL was transferred into a well of 
the 96-well plate and incubated at 30°C with 
vigorous orbital shaking (800 rpm) on a titer 
plate shaker (TITRAMAX 1000; Heidolph 
Instruments GmbH, Hamburg, Germany) 
for 2 hr, and the cell density of the culture was 
measured at OD600 (GENios A-5002; Tecan 
Austria GmbH, Salzburg, Austria). Then, 
50 µL test culture was transferred to a new 
96-well plate, and after addition of 120 µL 
Z-buffer (21.51 g/L Na2HPO4·12H2O; 
6.22 g/L NaH2PO4·2H2O; 0.75 g/L KCl; 
0.25 g/L MgSO4·7H2O) and 20 µL chlo-
roform, the cultures were carefully mixed 
and pre  incubated for 10 min at 30°C and 
13,000 rpm. The enzyme reaction was started 
by adding 40 µL o-NPG (13.3 mM, dissolved 
in yeast-based buffer). The assay culture was 
further incubated at 30°C for 1 hr. Finally, 
the reactions were terminated by the addi-
tion of 100 µL sodium carbonate (1 M). The 
resulting absorption was meas  ured at 420 nm. 
The β-galactosidase activity (U) was calculated 
according to the following equation:
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where U is the activity of β-galactosidase, t is 
the incubation duration of the enzyme reac-
tion, V is the volume of the test culture, D 
is the diluting factor (6.6), OD600 is the cell 
density measured at 600 nm, and OD420 and 
OD´420 are the cell density of the enzymic 
reaction supernatant and the blank, respec-
tively, measured at 420 nm.
The dose–response curves for U of the 
tested compounds were fitted by iterative four-
parameter curve fit method using SigmaPlot, 
version 10.0 (Systat Software Inc., Chicago, 
IL, USA). The concentration inducing 20% 
of the maximum effect (REC20) value was cal-
culated from the fitted dose–response curves. 
We evaluated the statistical significance of dif-
ferences by analysis of variance (we considered 
p < 0.05 significant).
Molecular docking.  We adapted the 
CDOCKER algorithm to find the binding 
mode for HO-PBDEs to TRβ. CDOCKER 
is an implementation of a CHARMM 
(Chemistry at HARvard Macromolecular 
Mechanics)-based docking tool that has been 
shown to be viable (Wu et al. 2003). It has 
been incorporated into Discovery Studio 2.1 
(Accelrys Software Inc., San Diego, CA) 
through the Dock Ligands (CDOCKER) 
protocol. We extracted the crystal structure 
of TRβ (Thyroid receptor beta1 in complex 
with a beta-selective ligand; PDB ID 1NAX) 
from the RCSB Protein Data Bank [RCSB 
(Research Collaboratory for Structural 
Bioinformatics) PDB; http://www.rcsb.org/
pdb]. In CDOCKER, random ligand confor-
mations were generated from the initial ligand 
structure through high-temperature molecular 
dynamics followed by random rotations. Then, 
the random conformations were refined by 
grid-based simulated annealing, which makes 
the results more accurate. The CDOCKER 
interaction energy between the ligand and TRβ 
(Ebinding) was then computed. The docking 
analysis provided insights into the inter  actions 
between the ligands and the receptor, which 
facilitated the selection of appropriate molecu-
lar parameters to charac  terize the interactions 
in the QSAR studies.
Molecular structural descriptor generation 
and QSAR development. We hypothe  sized that 
the thyroid hormone activities of HO-PBDEs 
were dependent on a) the partition of the com-
pounds between water and the biophase, and 
b) the interaction between the ligands and the 
receptor TRβ. Thus, 12 theoretical param-
eters were computed and selected to charac-
terize the processes: the logarithm of octanol/
water partition coefficient (logKow), average 
molecular polarizability (α), molecular volume 
(V), dipole moment (µ), energy of the highest 
occupied molecular orbital (EHOMO), energy 
of the lowest unoccupied molecular orbital 
(ELUMO), formal charge on hydroxyl hydro-
gen atoms (qOH –), formal charge on hydroxyl 
oxygen atoms (qO –H), formal charge on ether 
oxygen atoms (qO), electrophilicity index 
(ω), harmonic oscillator model of aromatic-
ity index (IA), and the number of bromine 
atoms (nBr) [see also Supplemental Material, 
Table S1 (doi:10.1289/ehp.0901457)]. We 
purposely selected logKow to describe the par-
tition process. The parameters V, nBr, α, and 
µ also partly describe partition because many 
of these parameters correlate with logKow 
(Nguyen et al. 2005). The parameters EHOMO, 
ELUMO, qOH –, qO –H, qO, ω, and IA were pur-
posely selected to describe the inter  molecular 
electro  static inter  actions between the ligands 
and TRβ. The quantum chemical parameters 
EHOMO, ELUMO, qOH –, qO –H, and qO proved 
successful in many QSAR studies for character-
izing inter  molecular electro  static inter  actions 
(Colosi et al. 2006). ω measures the ability of 
a compound to soak up electrons. The relative 
binding affinity of some estrogen derivatives 
correlated strongly with ω (Chattaraj 2006). 
The aromaticity of compounds (IA) may influ-
ence their non  covalent inter  actions with the 
receptor, and IA has been used to charac  terize 
halogenated biphenyls (Alonso et al. 2008).
We computed logKow values using the 
EPI Suite, version 4.0 (U.S. Environmental 
Protection Agency 2009). V (defined as the 
volume inside a contour of 0.001 electrons/
bohr3 density) and the quantum chemical 
parameters were computed by the Gaussian 
03 programs (Frisch et al. 2004). Initial geom-
etries of HO-PBDEs were pre  optimized by 
semi  empirical PM3 Hamiltonian and then 
optimized by density functional theory at the 
B3LYP/6-311+G(d,p) level. Frequency analysis 
was performed on the optimized geometries to 
ensure the systems had no imaginary vibration 
frequencies. IA was calculated by DRAGON 
software (Todeschini and Consonni 2000). 
The 18 HO-PBDEs were randomly 
divided into a training set (80%) and a vali-
dation set (20%), as listed in Table 1. Partial 
least squares (PLS) regression was performed in Li et al.
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developing the model because PLS can analyze 
data with strongly collinear, noisy, and numer-
ous predictor variables (Wold et al. 2001). We 
used Simca-S (version 6.0; Umetri AB, Umea, 
Sweden) for the PLS analysis. Simca-S uses 
leave-many-out cross-validation to determine 
the number of PLS components (A). Cross-
validation simulates how well a model predicts 
new data and gives a statistical fraction of the 
total variation of the dependent variables that 
can be predicted by all the extracted compo-
nents (Q2
CUM) for the final model. The PLS 
analysis was performed repeatedly to eliminate 
redundant molecular structural parameters, 
as done in our previous studies (Chen et al. 
2004). Model predictability was evaluated by 
external validation, which was characterized by 
the determination coefficient (R2), root mean 
square error (RMSE), and external explained 
variance (Q2
EXT), which are defined as follows 
(Schüürmann et al. 2008):
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where yi
fit is the fitted –logREC20 value of the 
ith compound; ¯y   is the average response value 
in the training set; yi and ˆ yi are the observed 
and predicted values for the ith compound, 
respectively; ¯y EXT is the average response value 
of the validation set; n is the number of com-
pounds in the training set; and nEXT is the 
number of compounds in the validation set.
We assessed the AD of the developed 
QSAR model using the Williams plot, that 
is, the plot of standardized residuals (σ) versus 
leverage (hat diagonal) values (hi) (Eriksson 
et al. 2003). We calculated σ as follows:
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where yi and ˆ yi are the observed and predicted 
values for the ith compound, respectively, 
and n is the number of compounds in the 
training set.
The hi value of a chemical in the original 
variable space and the warning leverage value 
(h*) are defined as follows:
 h i = xi
T(XTX)–1xi (i = 1, . . . , n),  [6]
 h * = 3(p + 1)/n,  [7]
where xi is the descriptor vector of the con-
sidered compound, X is the model matrix 
derived from the training set descriptor values, 
and p is the number of predictor variables.
Results and Discussion
Thyroid hormone activity determined by 
recombined yeast. Based on a plot of U ver-
sus log T3 concentrations, the maximal induc-
tion of T3 was achieved at 1.0 × 10–6 M [see 
Supplemental Material, Figure S2 (doi:10.1289/
ehp.0901457)]. From the dose–response curve, 
the median effective concentration value 
of T3 was 1.4 × 10–7 M, which was similar 
to that reported by Li et al. (2008). The 18 
tested HO-PBDEs induced β-galactosidase 
activity in a concentration-dependent man-
ner in the concentration range from 10–11 to 
10–6 M (see Supplemental Material, Figure S3). 
Supplemental Material, Table S2 lists the deter-
mined REC20 values for the 18 HO-PBDEs. 
With 2 × 10–7 M of the tested com-
pounds, the PBDEs showed no significant 
β-galactosidase activity compared with 
DMSO, and HO-PBDEs exhibited significant 
activity [p < 0.05; see Supplemental Material, 
Figure S4 (doi:10.1289/ehp.0901457)]. 
Previous studies (Hamers et al. 2008; Meerts 
et al. 2000) indicated that HO metabolites of 
PBDEs could compete with T4 for binding 
to TTR and exert thyroid hormone activity. 
Kitamura et al. (2008) reported that 4-OH-
BDE-90 and 3-OH-BDE-47 markedly inhib-
ited the binding of T3 to TRα and acted as 
thyroid hormone-like agents. Kojima et al. 
(2009) reported that 4-HO-BDE-90 signif-
icantly inhibited TRα- and TRβ-mediated 
transcriptional activity induced by T3. Thus, 
with respect to the observed thyroid hormone 
activity of HO-PBDEs, our results are consis-
tent with previous findings.
Docking analysis. Figure 1 shows the dock-
ing view of T3 and representative HO-PBDEs 
and PBDEs (4-OH-BDE-42, 4´-OH-BDE-17, 
and BDE-116) in the binding site of TRβ. 
At the deep end of the pocket, Arg282 and 
Ile275 serve as anchoring points for the ligands. 
The ligands also interact with the second polar 
region within the binding pocket, Leu341. We 
observed hydrogen bonding to be a charac-
teristic inter  action. As shown in Figure 1B 
and C, there are mainly two types of hydrogen 
bonds: those formed between the hydroxyl oxy-
gen of HO-PBDEs and the hydrogen of Arg282 
and Ile276, and those between the hydroxyl 
hydrogen of HO-PBDEs and the carbonyl oxy-
gen of Leu341. However, for BDE-116, we 
could find no hydrogen bonds with the amino 
acid residues in TRβ. We also observed π–π 
inter  actions between the phenyl of HO-PBDEs 
and Phe272, Phe442, and Phe455.
The ligand–receptor binding energy (Ebinding) 
of the 18 HO-PBDEs is listed in Table 1. As 
shown in Figure 2, we obtained a simple linear 
free energy relationship between –logREC20 
and Ebinding, further proving that binding to 
TRβ is the key step for the HO-PBDEs to 
exert their thyroid hormone activity. However 
Ebinding itself was not a good predictor for 
–logREC20, as indicated by the big prediction 
residuals for some HO-PBDEs (Figure 2). This 
was expected because Ebinding values calculated 
by CDOCKER differed from the real binding 
energy because the environmental factors (e.g., 
solvents, pH, and ions) were not considered in 
the modeling, and the ability of β-galactosidase 
expression for different HO-PBDEs may differ. 
Table 1. −LogREC20 and Ebinding values for selected compounds.
−LogREC20
Compound Observed Predicted Residual Ebinding (kJ/mol)
3´-OH-BDE-7a 7.64 7.03 0.61 –35.3
4´-OH-BDE-17 8.66 9.05 –0.39 –39.8
3´-OH-BDE-28 7.28 7.75 –0.47 –38.9
2´-OH-BDE-28 8.07 7.95 0.12 –35.8
4-OH-BDE-42 9.72 8.90 0.82 –43.7
4´-OH-BDE-49 7.87 8.31 –0.44 –43.6
3-OH-BDE-47 8.77 8.91 –0.14 –40.0
5-OH-BDE-47a 8.44 9.18 –0.74 –40.2
6-OH-BDE-47a 10.43 9.85 0.58 –38.8
4-OH-BDE-90 7.63 7.96 –0.33 –41.3
6-OH-BDE-85 9.77 9.79 –0.02 –44.3
6-OH-BDE-87a 9.29 9.65 –0.36 –42.0
6-OH-BDE-82 10.44 10.55 –0.11 –44.2
6´-OH-BDE-99 9.62 9.93 –0.31 –39.6
5´-OH-BDE-99 10.34 9.73 0.61 –44.4
6-OH-BDE-157 12.20 11.97 0.23 –46.3
6-OH-BDE-140 11.31 11.80 –0.49 –47.8
3´-OH-BDE-154 10.76 9.91 0.85 –42.0
BDE-30 < 6.70 –37.0
BDE-116 < 6.70 –34.4
aCompound selected to form the external validation set.Thyroid hormone activity of HO-PBDEs and QSAR
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Thus, it is necessary to develop multi  parameter 
QSAR models for –logREC20 prediction.
Development, validation, and AD of the 
QSAR. PLS analysis with –logREC20 as the 
dependent variable and the molecular struc-
tural parameters as predictor variables resulted 
in the following optimal QSAR model:
–logREC20 = 5.73 × 10 + 8.01 × 10–1 nBr  
  + 9.62 × 10–1 logKow  
  – 4.95 × 10 IA + 2.84 ELUMO  
  – 1.66 ω + 3.26 × 10–2 µ2,
where n = 14, A = 3, R2 = 0.913, Q2
CUM = 
0.873, RMSE (training set) = 0.418, nEXT = 4, 
Q2
EXT = 0.500, and RMSE (validation set) = 
0.731 (p < 0.0001).
Q2
CUM of the QSAR was as high as 0.873, 
implying good robustness of the model. The 
differences between R2 and Q2
CUM did not 
exceed 0.3, indicating no over  fitting in the 
model (Golbraikh and Tropsha 2002). Figure 3 
shows that the predicted –logREC20 values are 
consistent with the observed values for both 
the validation and training sets. The model has 
good predictive abilities, as indicated by Q2
EXT 
= 0.500 and RMSE = 0.731.
The AD is shown by the Williams plot 
(Figure 4); hi values of all the compounds in 
the training and validation sets were lower than 
the warning value (h* = 1.500). Thus, none of 
the compounds are particularly influential in 
the model space, and the training set has great 
representativeness. The standardized residuals of 
all the compounds in the training and validation 
sets are < 3, so there are no out  liers in the devel-
oped QSAR model. Considering the mechanism 
of action, we can infer that the developed QSAR 
model can be used to predict thyroid hormone 
activity on TRβ of other HO-PBDEs similar to 
those used in the present study. To discriminate 
between active and inactive compounds (e.g., 
PBDEs and HO-PBDEs), discriminant models 
should be developed in further studies.
Mechanistic implication of the developed 
model. The developed PLS model extracted 
on three PLS components loaded primarily on 
six predictor variables. Values of the variable 
importance in the projection (VIP) and PLS 
weights (W*) are listed in Table 2. From the 
W* values, one can see how the predictor vari-
ables and the response variable combine in the 
projections (PLS components) and how they 
relate to each other.
The first PLS component (W*c[1]) is 
loaded primarily on three descriptors, nBr, log-
Kow, and IA (Table 2). These three descrip-
tors remarkably govern –logREC20 values, 
as indicated by their large VIP values among 
the predictor variables. The coefficients in the 
QSAR model indicate that –logREC20 values 
of HO-PBDEs increase with nBr and logKow 
values but decrease with increasing IA values. 
The observation is reasonable because log-
Kow correlates with nBr positively (r = 0.999, 
Figure 1. Docking views of T3 (A), 4-OH-BDE-42 (B), 4´-OH-BDE-17 (C), and BDE-116 (D) at the TRβ binding 
site. Green dashed lines indicate hydrogen bonds between HO-PBDEs and amino acid residues, gray is car-
bon, red is oxygen, blue is nitrogen, purple is iodine, and white is hydrogen. 
T3 4-OH-BDE-42
4’-OH-BDE-17 BDE-116
Figure 2. Plot of observed –logREC20 versus the 
Ebinding. R = 0.685; p < 0.02. 
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Figure 4. Williams plot showing AD of the devel-
oped QSAR model (see also Equations 5 and 6). The 
vertical dashed line indicates that hi = h* = 1.500. 
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Table 2. VIP values and PLS weights for the optimal 
PLS model.
Variable VIP W*c[1] W*c[2] W*c[3]
nBr 1.093  0.487  0.194  0.585
LogKow 1.091  0.487  0.191  0.581
IA 1.022  –0.420  –0.589  –0.246
ELUMO 0.980  –0.387  0.469  0.615
ω 0.979  0.392  –0.451  –0.592
µ2 0.806  0.215  0.428  –0.345Li et al.
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p < 0.001) and because HO-PBDEs with 
large logKow and nBr values tend to partition 
into the biophase (yeast cells). The harmonic 
oscillator model of aromaticity index (IA) may 
characterize the non  covalent inter  actions with 
TRβ. The deviation from planarity of an aro-
matic ring is a structural measurement of aro-
maticity: The higher the planarity, the higher 
the π electron delocalization and the higher 
the aromaticity (Alonso et al. 2008). Even for 
a single ring of polychlorinated biphenyl, aro-
maticity varied with the number of chlorine 
atoms (Alonso et al. 2008). Thus, the involve-
ment of IA in the QSAR model may imply 
the effects of planarity (or non  planarity) of 
HO-PBDE molecules on thyroid hormone 
activity. According to the QSAR model, IA 
plays a negative effect on thyroid hormone 
activity (n = 18; r = 0.66; p < 0.005). Ebinding 
also correlates positively with IA values (n = 18; 
r = 0.54; p < 0.05).
The second PLS component (W*c[2]) is 
loaded primarily on IA, ELUMO, ω, and µ2, and 
the third PLS component (W*c[3]) is loaded 
primarily on nBr, logKow, ELUMO, and ω. 
ELUMO itself has a negative value and measures 
the ability of a molecule to accept electrons. 
The docking analysis showed that hydrogen 
bonds were the charac  teristic inter  actions 
between the hydroxyl oxygen of HO-PBDEs 
and the hydrogen of Arg282 and Ile276. 
Because HO-PBDE molecules with lower 
ELUMO values tend to accept electrons easily, 
accept protons with difficulty, and accordingly 
form the hydrogen bonds with difficulty, the 
developed PLS model shows that –logREC20 
increases with ELUMO values. Likewise, 
because ω meas  ures the ability of a molecule 
to soak up electrons (Chattaraj 2006), in the 
developed PLS model –logREC20 increases 
with decreasing ω values. Finally, µ measures 
the dipole–dipole and dipole-induced inter-
actions between inter  acting molecules (Hurth 
et al. 2004), so HO-PBDEs with large µ val-
ues may exhibit strong dipole–dipole inter-
actions with the receptor (TRβ), leading to 
large –logREC20 values.
Conclusion
We determined thyroid hormone activities 
of selected HO-PBDEs by the recombinant 
two-hybrid yeast assay. Docking analysis indi-
cated that hydrogen bonding and electrostatic 
interactions are the key steps for HO-PBDEs 
to exert thyroid hormone activities. We devel-
oped a QSAR to characterize the inter  actions 
and model the thyroid hormone activities. 
The HO-PBDEs with higher ability to accept 
electrons (as indicated by ELUMO and ω) tend 
to have weak hydrogen bonding with the 
receptor and lower thyroid hormone activi-
ties. The developed QSAR model has good 
robustness, predictive ability, and mechanism 
interpretability.
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